| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200977 | Ophthalmology | 2015 | 14 Pages |
Abstract
Ranibizumab monotherapy or combined with laser showed superior BCVA improvements over laser treatment alone in Asian patients with visual impairment resulting from DME. No new ocular or nonocular safety findings were observed and treatment was well tolerated over 12 months.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tatsuro MD, Xiaoxin MD, Adrian MD, FRCS(Ed), Timothy Y.Y. MD, FRCOphth, Fenq-Lih MD, Won-Ki MD, PhD, Zhizhong MD, Masahito MD, Nikolle MD, Sung Bok MD, Jila PhD, C. Lillian PhD, REVEAL Study Group REVEAL Study Group,